Jellagen Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $2.38M
Latest Deal Amount
  • Investors
  • 11

Jellagen General Information

Description

Manufacturer of collagen products designed for application in 2D and 3D cell culture and medical devices. The company's products offer non-mammalian jellyfish collagen ranging from in-vitro to in-vivo applications as well as a batch to batch consistency offering advantages to research and medical applications, enabling medicinal researchers to conduct in-house research and development and to support fabrication of new medical devices offering new approaches to wound management and tissue engineering.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Unit G6 Capital Business Park, Parkway
  • Wentloog Industrial Estate
  • Cardiff CF3 2PX
  • Wales, United Kingdom
+44 0333 000 0000

Jellagen Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jellagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 25-Jun-2020 $2.38M 000.00 0000 Completed Generating Revenue
6. Early Stage VC 09-Apr-2019 00000 00.00 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 20-Feb-2019 00000 00.000 Completed Generating Revenue
4. Early Stage VC 27-Apr-2018 00.000 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 15-Dec-2016 00.00 00.00 00.000 Completed Startup
2. Early Stage VC 02-Sep-2015 $895K $895K 00.000 Completed Startup
1. Grant 17-Aug-2015 $3.07M Completed Startup
To view Jellagen’s complete valuation and funding history, request access »

Jellagen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preferred Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.00
Ordinary A 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preferred Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00
Preferred Ordinary 4,227 $0.012506 $118.36 $118.36 1x $118.36 5.82%
A Ordinary 1,849 $0.012506 $118.36 $118.36 1x $118.36 2.54%
To view Jellagen’s complete cap table history, request access »

Jellagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of collagen products designed for application in 2D and 3D cell culture and medical devices. The company's
Biotechnology
Cardiff, United Kingdom
11 As of 2020
000.00
000 0000-00-00
000000000 000.00

00000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000000000000
Cheshire, United Kingdom
0 As of 0000
00.000
0.000 0000-00-00
0000000000 0 00.000

00000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000000000000
San Diego, CA
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jellagen Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Manchester BIOGEL Venture Capital-Backed Cheshire, United Kingdom 0 00.000 0000000000 0 00.000
00000000 000000000 Venture Capital-Backed San Diego, CA 00000 00000
000000 00000000000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
00000000 Private Equity-Backed Chaponost, France 00 000000
0000000000000 Corporation Canton, MA 000 00000 00000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Jellagen Executive Team (6)

Name Title Board Seat Contact Info
Thomas-Paul Descamps Chief Executive Officer, Executive Director & Board Member
Stephen Fairey Chief Financial Officer, Member of the Executive Committee and Board Observer
Andrew Mearns-Spragg Ph.D Co-Founder, Chief Scientific Officer, Executive Director & Chairman, Science Advisory Board
Almero Barnard Chief Manufacturing Officer
Gregg Sando Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Jellagen Board Members (8)

Name Representing Role Since
Andrew Mearns-Spragg Ph.D Jellagen Co-Founder, Chief Scientific Officer, Executive Director & Chairman, Science Advisory Board 000 0000
Andrew Shearer Jellagen Board Observer & Business Development Advisor 000 0000
Berent Wallendahl Self Board Member 000 0000
Gregg Sando Self Chairman 000 0000
Jacques Tavernier Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Jellagen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jellagen Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angels Invest Wales Angel Group 000 0000 000000 0
MedCity Corporation Minority 000 0000 000000 0
Newable Corporation Minority 000 0000 000000 0
Angels in Med City Angel Group Minority 000 0000 000000 0
London Business Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »